Home › Upcoming votes › Chemomab Therapeutics Ltd.
The deadline as the proxy statement states it: “voting by mail, the proxy card must be received by no later than 11:59 p.m. (EDT) on December 3, 2026”. Shares held through a bank, a broker or a company plan can have a different deadline; the voting instruction form says.
Read the proxy statement on EDGAR
Ballot read from the proxy statement and checked. As listed in Chemomab Therapeutics Ltd.’s proxy statement, with the board’s recommendation on each item.
| # | Item | Proposed by | Board recommends |
|---|---|---|---|
| 1 | Approve and adopt the Merger Agreement and the Merger | Board | For |
| 2 | Approve the Domestication Merger | Board | For |
| 3 | Nasdaq stock issuance in the concurrent PIPE | Board | For |
| 4 | Election of directors to the Chemomab Parent board Director election |
Board | For |
| 5 | Approve the Scipher Medicine Corporation 2026 Equity Incentive Plan | Board | For |
| 6 | Approve the Scipher Medicine Corporation 2026 Employee Stock Purchase Plan | Board | For |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.